Xgeva 120 mg vial s.c. inj

Xgeva 120 mg vial s.c. inj

3726.50 جنيها

معلومات الدواء

الإسم التجاري

Xgeva 120 mg vial s.c. inj -

الإسم العلمي 

Denosumab

الشركات المنتجة

Amgen, Multipharma,
Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.the most common side effects are joint and muscle pain in the arms or legs. denosumab is contraindicated in people with low blood calcium levels. denosumab is a rankl inhibitor, which works by preventing the development of osteoclasts which are cells that break down bone. denosumab is used for those with osteoporosis at high risk for fractures, bone loss due to certain medications, and in those with bone metastases.
Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.the most common side effects are joint and muscle pain in the arms or legs. denosumab is contraindicated in people with low blood calcium levels. denosumab is a rankl inhibitor, which works by preventing the development of osteoclasts which are cells that break down bone. denosumab is used for those with osteoporosis at high risk for fractures, bone loss due to certain medications, and in those with bone metastases.

تنبيه بخصوص المعلومات المتوفرة علي موقع دليل الدواء

بينما نعمل دائما علي تنقيح وتحسين البيانات المعروضة علي موقعنا إلا أننا ننصح دائما بعدم تعاطي أي دواء بدون إستشارة الطبيب المختص، ولا يتحمل الموقع أي مسئولية ناتجة عن سوء استخدام الأدوية بدون استشارة المختص، في حال وجدت أي بيانات خاطئة أو سعر دواء غير صحيح برجاء الإتصال بنا لتصحيحه.
الإبلاغ عن مشكلة

البدائل

0 دواء

لا يوجد بدائل مسجلة لدينا لهذا الدواء